Literature DB >> 29102179

Discovery of a fluorescent probe with HDAC6 selective inhibition.

Yingjie Zhang1, Jin Yan2, Tso-Pang Yao3.   

Abstract

There is increasing interest in discovering HDAC6 selective inhibitors as chemical probes to elucidate the biological functions of HDAC6 and ultimately as new therapeutic agents. Small-molecular fluorescent probes are widely used to detect target protein location and function, identify protein complex composition in biological processes of interest. In the present study, structural modification of the previously reported compound 4MS leads to two novel fluorescent HDAC inhibitors, 6a and 6b. Determination of IC50 values against the panel of Zn2+ dependent HDACs (HDAC1-11) reveals that 6b is a HDAC6 selective inhibitor, which can induce hyperacetylation of tubulin but not histone H4. Importantly, fluorescent and immunofluorescent analyses of cells treated with the proteasome inhibitor MG132 demonstrates that 6b can selectively target and image HDAC6 within the inclusion body, the aggresome. These results identify 6b not only as a HDAC6 selective inhibitor but also as a fluorescent probe for imaging HDAC6 and investigating the roles of HDAC6 in various physiological and pathological contexts.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aggresome; Fluorescent probe; HDAC6; Neurodegenerative disease

Mesh:

Substances:

Year:  2017        PMID: 29102179      PMCID: PMC5694690          DOI: 10.1016/j.ejmech.2017.10.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  44 in total

1.  Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.

Authors:  Jay H Kalin; Kyle V Butler; Tatiana Akimova; Wayne W Hancock; Alan P Kozikowski
Journal:  J Med Chem       Date:  2012-01-05       Impact factor: 7.446

2.  Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.

Authors:  Tatiana Akimova; Guanghui Ge; Tatiana Golovina; Tatiana Mikheeva; Liqing Wang; James L Riley; Wayne W Hancock
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

3.  Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor.

Authors:  Wenwen Duan; Jin Li; Elizabeth S Inks; C James Chou; Yuping Jia; Xiaojing Chu; Xiaoyang Li; Wenfang Xu; Yingjie Zhang
Journal:  J Med Chem       Date:  2015-05-07       Impact factor: 7.446

4.  HDAC6 is a target for protection and regeneration following injury in the nervous system.

Authors:  Mark A Rivieccio; Camille Brochier; Dianna E Willis; Breset A Walker; Melissa A D'Annibale; Kathryn McLaughlin; Ambreena Siddiq; Alan P Kozikowski; Samie R Jaffrey; Jeffery L Twiss; Rajiv R Ratan; Brett Langley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

Review 5.  Discerning the Chemistry in Individual Organelles with Small-Molecule Fluorescent Probes.

Authors:  Wang Xu; Zebing Zeng; Jian-Hui Jiang; Young-Tae Chang; Lin Yuan
Journal:  Angew Chem Int Ed Engl       Date:  2016-08-29       Impact factor: 15.336

6.  Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.

Authors:  You Me Sung; Taehee Lee; Hyejin Yoon; Amanda Marie DiBattista; Jung Min Song; Yoojin Sohn; Emily Isabella Moffat; R Scott Turner; Mira Jung; Jungsu Kim; Hyang-Sook Hoe
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

7.  HDAC6 regulates mitochondrial transport in hippocampal neurons.

Authors:  Sigeng Chen; Geoffrey C Owens; Helen Makarenkova; David B Edelman
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes.

Authors:  Sara S Hook; Amir Orian; Shaun M Cowley; Robert N Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-27       Impact factor: 11.205

9.  Aggresomes: a cellular response to misfolded proteins.

Authors:  J A Johnston; C L Ward; R R Kopito
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

10.  Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production.

Authors:  Bin Wang; Yan-Hua Rao; Makoto Inoue; Rui Hao; Chun-Hsiang Lai; David Chen; Stacey L McDonald; Moon-Chang Choi; Qiu Wang; Mari L Shinohara; Tso-Pang Yao
Journal:  Nat Commun       Date:  2014-03-17       Impact factor: 14.919

View more
  5 in total

Review 1.  Histone Deacetylases as Epigenetic Targets for Treating Parkinson's Disease.

Authors:  Yan Li; Zhicheng Gu; Shuxian Lin; Lei Chen; Valentina Dzreyan; Moez Eid; Svetlana Demyanenko; Bin He
Journal:  Brain Sci       Date:  2022-05-21

Review 2.  HDAC Inhibitors: Innovative Strategies for Their Design and Applications.

Authors:  Mateusz Daśko; Beatriz de Pascual-Teresa; Irene Ortín; Ana Ramos
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

3.  The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.

Authors:  Qi-Yue Chen; Xiao-Bo Huang; Ya-Jun Zhao; Hua-Gen Wang; Jia-Bin Wang; Li-Chao Liu; Ling-Qian Wang; Qing Zhong; Jian-Wei Xie; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Chao-Hui Zheng; Ping Li; Chang-Ming Huang
Journal:  Theranostics       Date:  2022-01-24       Impact factor: 11.556

Review 4.  Next-generation of selective histone deacetylase inhibitors.

Authors:  Feifei Yang; Na Zhao; Di Ge; Yihua Chen
Journal:  RSC Adv       Date:  2019-06-24       Impact factor: 4.036

5.  First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement.

Authors:  Daniel Herp; Johannes Ridinger; Dina Robaa; Stephen A Shinsky; Karin Schmidtkunz; Talha Z Yesiloglu; Theresa Bayer; Raphael R Steimbach; Corey J Herbst-Gervasoni; Annika Merz; Christophe Romier; Peter Sehr; Nikolas Gunkel; Aubry K Miller; David W Christianson; Ina Oehme; Wolfgang Sippl; Manfred Jung
Journal:  Chembiochem       Date:  2022-06-10       Impact factor: 3.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.